Hypoxic signals increase resistance to T cell-mediated killing by enhancing CTLA-4 expression on CD8+ T cells, as well as recruiting Tregs, myeloid-derived suppressor cells, and tumor associated macrophages (TAMs) into the TME (44). The gene discussed is CD8A; the disease is neoplasm.